Wendy B. Young, Director at Rapport Therapeutics, Inc. (RAPP), bought 3,500 shares at $22.60 ($79K) on 2025-09-11, disclosed to the SEC on 2025-09-11.
Open-market purchase of $79k RAPP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.